# Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

> **NCT04834934** · — · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 2000 (actual)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04834934
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-16
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2025-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834934, "Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04834934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*